These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7598302)

  • 1. Drug use in the nursing home.
    Avorn J; Gurwitz JH
    Ann Intern Med; 1995 Aug; 123(3):195-204. PubMed ID: 7598302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychopharmacologic interventions in nursing homes: what do we know and where should we go?
    Ryan JM; Kidder SW; Daiello LA; Tariot PN
    Psychiatr Serv; 2002 Nov; 53(11):1407-13. PubMed ID: 12407268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical care of nursing home residents.
    Evans JM; Chutka DS; Fleming KC; Tangalos EG; Vittone J; Heathman JH
    Mayo Clin Proc; 1995 Jul; 70(7):694-702. PubMed ID: 7791397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescribing psychoactive medications in nursing homes: current practice in Singapore.
    Mamun K; Goh-Tan CY; Ng LL
    Singapore Med J; 2003 Dec; 44(12):625-9. PubMed ID: 14770256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gerontopsychiatric competence is in demand. The current psychopharmacologic treatment practice in homes for the aged and nursing homes].
    Riedel-Heller SG; Stelzner G; Schork A; Angermeyer MC
    Psychiatr Prax; 1999 Nov; 26(6):273-6. PubMed ID: 10627955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes.
    Avorn J; Soumerai SB; Everitt DE; Ross-Degnan D; Beers MH; Sherman D; Salem-Schatz SR; Fields D
    N Engl J Med; 1992 Jul; 327(3):168-73. PubMed ID: 1608408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administrative initiatives for reducing inappropriate prescribing of psychotropic drugs in nursing homes: how successful have they been?
    Hughes CM; Lapane KL
    Drugs Aging; 2005; 22(4):339-51. PubMed ID: 15839722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polypharmacy in nursing home residents in the United States: results of the 2004 National Nursing Home Survey.
    Dwyer LL; Han B; Woodwell DA; Rechtsteiner EA
    Am J Geriatr Pharmacother; 2010 Feb; 8(1):63-72. PubMed ID: 20226393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Psychotropic drugs use in 3 geriatric homes].
    Pérez Poza A; Merino F; Freire I; Expósito A
    Aten Primaria; 1996 Jun; 18(2):100-1. PubMed ID: 8924563
    [No Abstract]   [Full Text] [Related]  

  • 10. [Determinants of psychotropic drug utilization in homes for the elderly and in nursing homes].
    Stelzner G; Riedel-Heller SG; Sonntag A; Matschinger H; Jakob A; Angermeyer MC
    Z Gerontol Geriatr; 2001 Aug; 34(4):306-12. PubMed ID: 11584715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A qualitative exploration of the chronic use of psychotropic drugs in nursing homes].
    Leten L; Azermai M; Wauters M; De Lepeleire J
    Tijdschr Gerontol Geriatr; 2017 Sep; 48(4):177-186. PubMed ID: 28688072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug overprescription in nursing homes: an empirical evaluation of administrative data.
    Stroka MA
    Eur J Health Econ; 2016 Apr; 17(3):257-67. PubMed ID: 25749894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Psychopharmaceutical prescriptions to older people. A comparison between patients in aged- and nursing homes, outpatient treatment with nursing care and outpatients without nursing care].
    Hach I; Rentsch A; Krappweis J; Kirch W
    Z Gerontol Geriatr; 2004 Jun; 37(3):214-20. PubMed ID: 15224242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing antipsychotic drug use in nursing homes. A controlled trial of provider education.
    Ray WA; Taylor JA; Meador KG; Lichtenstein MJ; Griffin MR; Fought R; Adams ML; Blazer DG
    Arch Intern Med; 1993 Mar; 153(6):713-21. PubMed ID: 8447709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of drugs in residents of homes for the elderly and nursing homes in comparison with patients in ambulatory care or without need of care].
    Pittrow D; Krappweis J; Kirch W
    Dtsch Med Wochenschr; 2002 Sep; 127(39):1995-2000. PubMed ID: 12324879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of psychopharmaceuticals in municipal nursing homes. A nationwide survey].
    Tybjerg J; Gulmann NC
    Ugeskr Laeger; 1992 Nov; 154(45):3126-9. PubMed ID: 1462408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effects of Antipsychotic Quality Reporting on Antipsychotic and Psychoactive Medication Use.
    Bowblis JR; Lucas JA; Brunt CS
    Health Serv Res; 2015 Aug; 50(4):1069-87. PubMed ID: 25600861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of neuroleptic drug use by nursing home elderly under proposed Medicare and Medicaid regulations.
    Garrard J; Makris L; Dunham T; Heston LL; Cooper S; Ratner ER; Zelterman D; Kane RL
    JAMA; 1991 Jan 23-30; 265(4):463-7. PubMed ID: 1670645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing psychotropic prescription by non-psychiatrist physicians in a nursing home for the elderly in Brazil.
    Stella F; Caetano D; Pacheco JL; Sé EV; Lacerda AL
    Sao Paulo Med J; 2006 Sep; 124(5):253-6. PubMed ID: 17262154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of psychotropic medication use among German and Austrian nursing home residents: a comparison of 3 cohorts.
    Richter T; Mann E; Meyer G; Haastert B; Köpke S
    J Am Med Dir Assoc; 2012 Feb; 13(2):187.e7-187.e13. PubMed ID: 21549645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.